ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,061Medicare Part D Prescriptions Filled, Including Refills

Rank: 147 out of 2456

$573K Total Retail Price of All Prescriptions

Rank: 172 out of 2456

847 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 847 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 847 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 6,496 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 568 385 1 1
SIMVASTATIN 493 367 2 2
AMLODIPINE BESYLATE 472 323 3 5
LEVOTHYROXINE SODIUM 440 260 4 4
OMEPRAZOLE 346 170 5 3
PRAVASTATIN SODIUM 313 248 6 15
HYDROCHLOROTHIAZIDE 302 213 7 7
METOPROLOL TARTRATE 291 190 8 10
SUBOXONE 269 0 9 62
FUROSEMIDE 202 156 10 8
PROAIR HFA 184 74 11 22
OXYCODONE-ACETAMINOPHEN 175 86 S2 12 35
METFORMIN HCL 172 89 13 11
ATENOLOL 163 127 14 6
HYDROCODONE-ACETAMINOPHEN 157 97 S3 15 20
METOPROLOL SUCCINATE 152 90 16 13
GABAPENTIN 145 61 17 16
ZOLPIDEM TARTRATE 141 79 18 28
OXYCODONE HCL 139 53 S2 19 38
ATORVASTATIN CALCIUM 125 107 20 12
DIOVAN 122 101 21 26
CITALOPRAM HBR 118 60 22 14
WARFARIN SODIUM 118 98 22 9
LANTUS 116 56 24 44
PANTOPRAZOLE SODIUM 112 63 25 37
TRAMADOL HCL 108 78 26 24
AZITHROMYCIN 104 60 27 60
TRAZODONE HCL 98 42 28 17
GLIPIZIDE 95 76 29 46
INSULIN SYRINGE 92 36 30 72
FLUTICASONE PROPIONATE 91 59 31 30
SPIRIVA 89 71 32 43
LOSARTAN POTASSIUM 82 62 33 18
GEMFIBROZIL 79 28 34 93
GLIPIZIDE ER 78 74 35 89
IBUPROFEN 78 0 35 52
ADVAIR DISKUS 77 41 37 36
TIZANIDINE HCL 74 17 38 212
PEN NEEDLE 73 37 39 150
CRESTOR 73 24 39 25
CIPROFLOXACIN HCL 72 47 41 87
NEXIUM 72 38 41 80
OXYCODONE HCL-ACETAMINOPHEN 70 0 S2 43 101
ALENDRONATE SODIUM 69 64 44 19
ACETAMINOPHEN-CODEINE 67 57 S3 45 106
TERAZOSIN HCL 67 67 45 76
CLONIDINE HCL 65 12 47 111
SERTRALINE HCL 64 35 48 21
OXYCONTIN 63 13 S2 49 129
CLOPIDOGREL 62 55 50 55
ISOSORBIDE MONONITRATE ER 61 51 51 48
PAROXETINE HCL 59 17 52 56
CYCLOBENZAPRINE HCL 59 11 R 52 77
TAMSULOSIN HCL 57 50 54 32
LANTUS SOLOSTAR 56 37 55 136
DONEPEZIL HCL 53 53 56 23
LORAZEPAM 52 52 57 67
ALLOPURINOL 52 52 57 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.